CTCL
FDA Agrees on Proposal for Initial Pediatric Study Plan for SGX301
Cecilia BrownT-Cell Lymphoma | November 14, 2022
SGX301 is a novel, first-in-class, photodynamic therapy utilizing visible light for activation.
Read More
Cusatuzumab Has Antitumor Activity in R/R CTCL
Leah SherwoodT-Cell Lymphoma | November 22, 2022
Cusatuzumab, a CD70-directed monoclonal antibody, had antitumor activity in highly pre-treated patients with CD70-positive ...
Read More
Topical Hypericin Photodynamic Therapy Effective for Early-Stage MF CTCL
Leah SherwoodT-Cell Lymphoma | January 24, 2023
Topical synthetic hypericin with visible light is a therapy for early-stage mycosis fungoides−cutaneous T-cell lymphoma.
Read More
Advertisement
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    Editorial Board

    About Us

    Terms of Use

    Advertising

    Privacy Policy

    Our Network

    MashupMD

    GU Oncology Now

    Cancer Nursing Today

    Urban Health Today

    DocWire News

    Connect

    eNewsletters

    Calendar of Events

    Contact Us

    Contribute

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |